Broadening the diagnostic approach for SARS‐CoV‐2 associated myopathy and rhabdomyolysis

With interest, we read the article by Sabljic et al. about a 63-year-old female with a second renal transplant under mycophenolate mofetil, tacrolimus, and steroids, who experienced a severe SARS-CoV-2 infection manifesting as pneumonia [1]. Her COVID-19 infection was managed with ceftriaxone, remdesivir, dexamethasone, tacrolimus reduction, and discontinuation of mycophenolate mofetil [1]. A few days after discharge, the patient developed...